Publicaciones científicas
SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
Y Escobar Álvarez 1 , R de Las Peñas Bataller 2 , J Perez Altozano 3 , S Ros Martínez 4 , A Sabino Álvarez 5 , A Blasco Cordellat 6 , E Brozos Vázquez 7 , J Corral Jaime 8 , I García Escobar 9 , C Beato Zambrano 10
Abstract
Anaemia is defined by the presence of haemoglobin (Hb) levels < 13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency.
Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice.
These guidelines review the available evidence on the use of different therapies for treating anaemia: erythropoiesis-stimulating agents, iron supplements, and transfusion of blood products.
CITA DEL ARTÍCULO Clin Transl Oncol. 2021 May;23(5):931-939. doi: 10.1007/s12094-021-02580-2. Epub 2021 Mar 25.